Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1989 | 03-1989 | 12-1988 | 09-1988 | 06-1988 | |
| Sales | 0 | 0 | -150 | 0 | 0 |
| Gross Profit | 0 | 0 | -150 | 0 | 0 |
| Operating Expenses | 3,188 | 2,522 | 3,372 | 3,401 | 2,187 |
| Operating Income | -3,188 | -2,522 | -3,522 | -3,401 | -2,187 |
| Interest Expense | 14 | 6 | 4 | 2 | 3 |
| Other Income | 909 | 76 | 233 | 55 | 102 |
| Pre-tax Income | -2,293 | -2,452 | -3,292 | -3,348 | -2,088 |
| Net Income Continuous | -2,293 | -2,452 | -3,292 | -3,348 | -2,088 |
| Net Income | $-2,293 | $-2,452 | $-3,292 | $-3,348 | $-2,088 |
| EPS Basic Total Ops | -22,925.00 | -24,520.00 | -32,922.00 | -33,482.00 | -20,882.00 |
| EPS Basic Continuous Ops | -22,925.00 | -24,520.00 | -32,922.00 | -33,482.00 | -20,882.00 |
| EPS Diluted Total Ops | -22,925.00 | -24,520.00 | -32,922.00 | -33,482.00 | -20,882.00 |
| EPS Diluted Continuous Ops | -22,925.00 | -24,520.00 | -32,922.00 | -33,482.00 | -20,882.00 |
| EBITDA(a) | $-3,188 | $-2,522 | $-3,522 | $-3,401 | $-2,187 |